Anti-Id Abs have been proposed as vaccines for cancer immunotherapy and significant success has been achieved using anti-Id vaccines mimicking tumor-associated antigens in animal studies [23]–[26] as well as in clinical trails [27]. Here, ID1 is linked to neoplasm.